Changes to the intermediate filament (IF) protein, vimentin, were found to promote tumor growth by increasing cancer stemness in an oestrogen independent manner. Targeting vimentin and/or the long noncoding RNA (lncRNA) 'XIST' could be an effective therapeutic strategy for treating aggressive breast cancer.
Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells ." ScienceDaily. ScienceDaily, 11 February 2025. <www.sciencedaily.comQueen Mary University of London. . Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells .Queen Mary University of London."Disruption of a single amino acid in a cellular protein makes breast cancer cells behave like stem cells ." ScienceDaily. www.
Research could provide a new approach to treating an aggressive form of breast cancer. A study found that targeting the immune microenvironment in lymph nodes and tumors simultaneously led to ... Researchers have identified extracellular vimentin as an attachment factor that facilitates SARS-CoV-2 entry into human cells. Vimentin is a structural protein that is widely expressed in the cells ...
In a new study, researchers have identified the presence of a specific connection between a protein and an lncRNA molecule in liver cancer. By increasing the presence of the lncRNA molecule, the fat ... A new study has identified an RNA molecule that suppresses prostate tumors. The scientists found that prostate cancers develop ways to shut down this RNA molecule to allow themselves to grow. ...Working Dogs Take a Day to Adjust to Daylight Savings Time, but Pets Are More Flexible
Cancer Lung Cancer Stem Cells Skin Cancer Prostate Cancer Brain Tumor Lymphoma
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ch-Ch-Changes: Chick-Fil-A Changes Fry Recipe + Customers Are Arguing!There are two types of people in this world: Those who like crispy french fries and those who like squishy ones — and you can't please everyone.
Read more »
Stress Granules: A New Theory for Understanding Alzheimer's DiseaseA groundbreaking theory proposes that stress granules, protein and RNA clumps that form in cells under stress, are central to the development of Alzheimer's disease. Disruption of nucleocytoplasmic transport by these granules could lead to widespread changes in gene expression, setting off the chain of events that characterize the disease. This theory suggests a potential for early intervention, targeting stress granule formation before the onset of symptoms.
Read more »
Researchers Uncover 3D Structure of RNA Enzyme SAMURIScientists led by Professor Claudia Höbartner at the University of Würzburg have revealed the 3D structure of SAMURI, a lab-generated RNA enzyme. This discovery provides insights into the development of ribozymes and the evolution of catalytically active RNA. SAMURI's unique ability to chemically modify other RNA molecules at specific sites and influence their function makes it a valuable subject of study.
Read more »
Textbooks need to be rewritten: RNA, not DNA, is the main cause of acute sunburnSunburn has traditionally been attributed to UV-induced DNA damage. However, a new study reveals that RNA, another vital cellular molecule, plays a major role in triggering acute sunburn reactions.
Read more »
What Can RNA Therapies Offer for Rheumatology?Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.
Read more »
Postdoctoral Researcher Position in RNA TherapeuticsHighly motivated postdoctoral researcher sought to join a lab focused on developing therapeutic RNAs. The candidate will leverage expertise in RNA biology, genomics, and computational biology to engineer novel therapeutic mRNAs, exploring innovative solutions for gene therapy and vaccine development. The position involves in vivo experiments, genomic analyses, tissue culture, and collaboration with experts in lipid nanoparticles.
Read more »